<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom"><title>HHS kratom decisions and a company in which the Homeland Security Secretary holds a stake (allegation) (INV-084): updates, Public Trust Tracker</title><id>https://publictrusttracker.org/case/inv-084-hhs-kratom-decisions-and-a-company-in-which-the-homeland/</id><link href="https://publictrusttracker.org/case/inv-084-hhs-kratom-decisions-and-a-company-in-which-the-homeland/"/><link rel="self" href="https://publictrusttracker.org/case/inv-084-hhs-kratom-decisions-and-a-company-in-which-the-homeland/feed.xml"/><updated>2026-10-14T00:00:00Z</updated><author><name>Public Trust Tracker</name></author><entry><title>INV-084, 14 Oct 2026: The DEA publishes a new notice of intent to temporarily place 7-hydroxymitragynine (7-OH)…</title><id>https://publictrusttracker.org/case/inv-084-hhs-kratom-decisions-and-a-company-in-which-the-homeland/#0207e3e90a</id><link href="https://publictrusttracker.org/case/inv-084-hhs-kratom-decisions-and-a-company-in-which-the-homeland/"/><updated>2026-10-14T00:00:00Z</updated><summary>The DEA publishes a new notice of intent to temporarily place 7-hydroxymitragynine (7-OH) and mitragynine pseudoindoxyl in Schedule I above a specified threshold, based on an 8 October 2026 HHS recommendation that replaces the lower threshold HHS gave earlier; it withdraws its July 2026 notice on 7-OH the same day. The notice gives no threshold figures.</summary></entry><entry><title>INV-084, 3 Aug 2026: Senate Finance ranking member Ron Wyden writes to HHS Secretary Kennedy and to Botanic…</title><id>https://publictrusttracker.org/case/inv-084-hhs-kratom-decisions-and-a-company-in-which-the-homeland/#bfc754ca35</id><link href="https://publictrusttracker.org/case/inv-084-hhs-kratom-decisions-and-a-company-in-which-the-homeland/"/><updated>2026-08-03T00:00:00Z</updated><summary>Senate Finance ranking member Ron Wyden writes to HHS Secretary Kennedy and to Botanic Tonics, answers due 31 Aug: &quot;I am opening an investigation into the kratom industry, your company&#x27;s relationship with Secretaries Kennedy and Mullin&quot;. The letters say Mullin &quot;has advocated for restrictions on kratom&#x27;s synthetic competitors while holding a sizable financial stake in Botanic Tonics&quot; and that the company has donated $1 million to MAHA PAC. The letter to Kennedy asks whether Mullin spoke with him about &quot;removing information on kratom from federal government websites&quot;. No reply reported.</summary></entry><entry><title>INV-084, 1 Jul 2026: The DEA announces a plan to temporarily place 7-OH products with certain concentrations,…</title><id>https://publictrusttracker.org/case/inv-084-hhs-kratom-decisions-and-a-company-in-which-the-homeland/#3e96096da9</id><link href="https://publictrusttracker.org/case/inv-084-hhs-kratom-decisions-and-a-company-in-which-the-homeland/"/><updated>2026-07-01T00:00:00Z</updated><summary>The DEA announces a plan to temporarily place 7-OH products with certain concentrations, and three 7-OH derivatives, in Schedule I for two years (as described in Sen. Wyden&#x27;s letter). These are synthetic competitors of natural-leaf kratom products like the company&#x27;s.</summary></entry><entry><title>INV-084, 16 Jun 2026: (Allegation, four unnamed people) The New York Times reports that Mullin, while a…</title><id>https://publictrusttracker.org/case/inv-084-hhs-kratom-decisions-and-a-company-in-which-the-homeland/#044f7feb65</id><link href="https://publictrusttracker.org/case/inv-084-hhs-kratom-decisions-and-a-company-in-which-the-homeland/"/><updated>2026-06-16T00:00:00Z</updated><summary>(Allegation, four unnamed people) The New York Times reports that Mullin, while a senator, urged health officials to remove warnings about kratom from the FDA website. Records obtained by the Times show the FDA was asked to remove links to enforcement actions against the company and others; the links were removed by the end of 2025.</summary></entry><entry><title>INV-084, 17 Mar 2026: The Office of Government Ethics certifies Markwayne Mullin&#x27;s financial disclosure as…</title><id>https://publictrusttracker.org/case/inv-084-hhs-kratom-decisions-and-a-company-in-which-the-homeland/#04d7341f4f</id><link href="https://publictrusttracker.org/case/inv-084-hhs-kratom-decisions-and-a-company-in-which-the-homeland/"/><updated>2026-03-17T00:00:00Z</updated><summary>The Office of Government Ethics certifies Markwayne Mullin&#x27;s financial disclosure as nominee for Homeland Security Secretary. It lists &quot;Botanic Tonics LLC (wellness tonics)&quot; valued at $500,001 to $1,000,000. His ethics agreement of the same date does not list the company among the assets he will divest.</summary></entry></feed>
